When does economic model type become a decisive factor in health technology appraisals? Learning from the expanding treatment options for relapsing–remitting multiple sclerosis

Kathleen Mary Noon, Stephen Maxwell Montgomery, Nicholas Edward Adlard, Nicholas Edward Adlard, Michel Anton Kroes
  • Journal of Medical Economics, July 2018, Taylor & Francis
  • DOI: 10.1080/13696998.2018.1491007
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Michel Kroes

In partnership with: